RYAN CHARLES S. (President) purchased 65.3% of their position (48.39K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $31.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/22/2024ACC: 0001415889-24-022054
Officer· President
Since Sep 2023
+48.39K
Net shares
Net buyer
$31.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
48.39K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+48.39K
Price / share
$0.65
Trade value
$31.45K
% of position
65.3%
8/20/2024
74.07K→122.46K
Total
Net shares
+48.39K
Net value
$31.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2024 | P · Purchase | +48.39K | $0.65 | $31.45K | 65.3% | 74.07K | 122.46K |
| Total | +48.39K | $31.45K | ||||||
Derivative Transactions0
No derivative transactions reported